A proposed Center for Cannabis Research and Policy could serve as a statewide hub uniting social policy research with ...

Kentucky’s medical marijuana program is getting off the ground. Here’s what you need to know about who can buy.

But today, with valuations coming down significantly across the board and recent news that President Trump signed an ...

In light of President Donald Trump’s December executive order urging for the reclassification of cannabis to a Schedule III ...

These initiatives represent the first-ever large-scale coordinated attack on adult-use markets… This is not a drill. It is ...

Company purchased out of receivership to acquire brand assets and provide working capital for growth; former Curaleaf CEO Joe ...

Using a technique called ancestral sequence reconstruction (ASR), researchers at Wageningen University & Research in the ...

Investing in cannabis stocks is back in focus as regulatory progress and expanding medical use steadily lift demand. The ...

Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith ...

“The facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when ...

First, the market momentum for Mirum's rare liver disease drug Livmarli should continue. Sales increased 56% year-over-year ...

Canadian stocks trade near record highs as investors stay risk-on, with mid-cap opportunities emerging despite stretched ...